Status: current, Defined. Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
3699384012 | Fluticasone propionate 250 microgram and salmeterol (as salmeterol xinafoate) 25 microgram/actuation pressurized suspension for inhalation | en | Synonym | Active | Case insensitive | SNOMED CT core |
3700151013 | Fluticasone propionate 250 microgram and salmeterol (as salmeterol xinafoate) 25 microgram/actuation pressurised suspension for inhalation | en | Synonym | Active | Case insensitive | SNOMED CT core |
5074221019 | Product containing precisely fluticasone propionate 250 microgram and salmeterol (as salmeterol xinafoate) 25 microgram/1 actuation conventional release pressurized suspension for inhalation (clinical drug) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Fluticasone propionate 250 microgram and salmeterol (as salmeterol xinafoate) 25 microgram/actuation pressurised suspension for inhalation | Is a | Fluticasone and salmeterol only product in pulmonary dose form | true | Inferred relationship | Some | ||
Fluticasone propionate 250 microgram and salmeterol (as salmeterol xinafoate) 25 microgram/actuation pressurised suspension for inhalation | Has presentation strength numerator unit | mcg | true | Inferred relationship | Some | 2 | |
Fluticasone propionate 250 microgram and salmeterol (as salmeterol xinafoate) 25 microgram/actuation pressurised suspension for inhalation | Has presentation strength denominator unit | Actuation | true | Inferred relationship | Some | 1 | |
Fluticasone propionate 250 microgram and salmeterol (as salmeterol xinafoate) 25 microgram/actuation pressurised suspension for inhalation | Is a | Fluticasone- and salmeterol-containing product | false | Inferred relationship | Some | ||
Fluticasone propionate 250 microgram and salmeterol (as salmeterol xinafoate) 25 microgram/actuation pressurised suspension for inhalation | Has manufactured dose form | Pressurised suspension for inhalation | true | Inferred relationship | Some | ||
Fluticasone propionate 250 microgram and salmeterol (as salmeterol xinafoate) 25 microgram/actuation pressurised suspension for inhalation | Has presentation strength denominator unit | Actuation | true | Inferred relationship | Some | 2 | |
Fluticasone propionate 250 microgram and salmeterol (as salmeterol xinafoate) 25 microgram/actuation pressurised suspension for inhalation | Count of base of active ingredient | 2 | false | Inferred relationship | Some | ||
Fluticasone propionate 250 microgram and salmeterol (as salmeterol xinafoate) 25 microgram/actuation pressurised suspension for inhalation | Is a | Product manufactured as pulmonary dose form | false | Inferred relationship | Some | ||
Fluticasone propionate 250 microgram and salmeterol (as salmeterol xinafoate) 25 microgram/actuation pressurised suspension for inhalation | Has unit of presentation | Actuation | true | Inferred relationship | Some | ||
Fluticasone propionate 250 microgram and salmeterol (as salmeterol xinafoate) 25 microgram/actuation pressurised suspension for inhalation | Has presentation strength numerator unit | mcg | true | Inferred relationship | Some | 1 | |
Fluticasone propionate 250 microgram and salmeterol (as salmeterol xinafoate) 25 microgram/actuation pressurised suspension for inhalation | Has presentation strength denominator value | 1 | false | Inferred relationship | Some | 1 | |
Fluticasone propionate 250 microgram and salmeterol (as salmeterol xinafoate) 25 microgram/actuation pressurised suspension for inhalation | Has presentation strength denominator value | 1 | false | Inferred relationship | Some | 2 | |
Fluticasone propionate 250 microgram and salmeterol (as salmeterol xinafoate) 25 microgram/actuation pressurised suspension for inhalation | Has precise active ingredient | Fluticasone propionate | true | Inferred relationship | Some | 2 | |
Fluticasone propionate 250 microgram and salmeterol (as salmeterol xinafoate) 25 microgram/actuation pressurised suspension for inhalation | Has precise active ingredient | Salmeterol xinafoate | true | Inferred relationship | Some | 1 | |
Fluticasone propionate 250 microgram and salmeterol (as salmeterol xinafoate) 25 microgram/actuation pressurised suspension for inhalation | Has presentation strength numerator value | 250 | false | Inferred relationship | Some | 2 | |
Fluticasone propionate 250 microgram and salmeterol (as salmeterol xinafoate) 25 microgram/actuation pressurised suspension for inhalation | Has BoSS | Salmeterol | true | Inferred relationship | Some | 1 | |
Fluticasone propionate 250 microgram and salmeterol (as salmeterol xinafoate) 25 microgram/actuation pressurised suspension for inhalation | Has presentation strength numerator value | 25 | false | Inferred relationship | Some | 1 | |
Fluticasone propionate 250 microgram and salmeterol (as salmeterol xinafoate) 25 microgram/actuation pressurised suspension for inhalation | Has BoSS | Fluticasone propionate | true | Inferred relationship | Some | 2 |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets